LAWRENCE, Mass., July 19, 2010 /PRNewswire vi COMTEX/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that it signed a five-year distribution agreement with Spindial S.p.A., a distributor of renal care products, for the promotion, sale, delivery and service of the NxStage System One(TM) and certain of the Company's in-center products in Italy.
Read Full Article:
http://www.nxstage.com/ir.cfm?c=1420...8919&highlight=
|
|
| In The News | ||
12/2/2011 Home Dialysis Central listed an important study from Finland in their monthly newsletter showing significant improvement of employment among home hemodialysis patients compared to usual in-center dialysis patients. 12/2/2011 (NEW YORK, NY)—November 28, 2011 — While 382,000 patients in the U.S. receive dialysis treatment for kidney failure, only 35,000 dialyze at home. A special report in the December issue of the American Journal of Kidney Diseases, the official journal of the National Kidney Foundation, suggests that as a result of systematic barriers, patients are not always receiving the option of home dialysis. Dialysis Data, Once Confidential, Shines Light on Clinic Disparitiesby Robin Fields For years, the government has collected a rich store of data about the performance of individual dialysis facilities. But it has kept nearly all the information secret from those it might benefit most: Patients. Dialysis Facility TrackerBy Robin Fields, Al Shaw, and Jennifer LaFleur, ProPublica, Dec. 22, 2010 This site is for dialysis patients and others who want to learn about the quality of care at individual dialysis clinics. Among other things, you can learn how often patients treated at a facility have been hospitalized, report certain types of infections or are placed on the transplant list. The information is submitted by facilities and collected by contractors of the Centers for Medicaid and Medicare Services, the federal agency that oversees most dialysis care.
by Robin Fields Patients treated at dialysis clinics run by the largest U.S. for-profit chains have a higher risk of death than patients treated by the biggest nonprofit chain, a study released today in the journal Health Services Research concludes. The outcome gaps are substantial: Patients at the largest for-profit chain were found to have a 19 percent higher risk of death than patients receiving care at the nonprofit; at the second-largest chain, the risk was 24 percent
NxStage's Medisystems introduces Vasc-Alert™
|
AN ESTIMATED 31 MILLION AMERICANS— 16 percent of the population—have a form of CKD and 506,000 Americans are being treated for ESRD. Unfortunately, the nephrologist population isn’t keeping pace with the exploding CKD and dialysis patient population. |
The Numbers Game
There is a gap between the rate of growth of ESRD patients and nephrologists, said Mark E. Mazak, vice president, DaVita Practice Strategy Group. He added that the number of ESRD patients is increasing 5.8 percent each year, whereas the number of nephrologists is “generously estimated” to be increasing about 3 percent each year.
According to Martin Osinski, president of NephrologyUSA and past president of the National Association of Physician Recruiters, the projected increase in the number of CKD and ESRD patients will have a big affect on the quality of care a patient receives because, while there is a small increase in the overall number of nephrologists, the numbers are not keeping up with the growth in CKD and ESRD. This means physicians will be stretched and not as available to patients when needed. “I think you are going to see more forced dependency on extenders,” he said. “As the physicians are overstretched the issue of maintaining a high quality of care becomes a concern.”
Read Rull Article
|
How do I get on Nocturnal Dialysis |
|---|
by Dialysis Dan
|
||
Copyright 2007-2012